InSilico Medicine Cayman TopCo (HKG:3696)

HKG:3696 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 29, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	24,075	20,641	-	-	-
Market Cap Growth	-	-	-	-	-
Enterprise Value	20,640	19,026	-	-	-
Last Close Price	42.06	37.14	-	-	-
PS Ratio	55.00	47.15	-	-	-
PB Ratio	6.84	5.87	-	-	-
P/TBV Ratio	6.85	5.87	-	-	-
EV/Sales Ratio	47.15	43.47	-	-	-
Debt / Equity Ratio	0.01	0.01	0.00	0.00	-0.01
Net Debt / Equity Ratio	-0.98	-0.98	0.19	0.27	0.46
Net Debt / EBITDA Ratio	7.70	7.70	3.75	2.17	2.58
Net Debt / FCF Ratio	5.54	5.54	2.12	5.45	3.50
Asset Turnover	0.18	0.18	0.50	0.23	-
Quick Ratio	13.93	13.93	0.16	0.21	0.31
Current Ratio	13.99	13.99	0.17	0.22	0.32
Return on Assets (ROA)	-11.83%	-11.83%	-13.46%	-23.92%	-
Return on Capital Employed (ROCE)	-13.20%	-13.20%	5.60%	12.90%	17.90%
Earnings Yield	-11.39%	-13.29%	-	-	-
FCF Yield	-2.57%	-3.00%	-	-	-
Buyback Yield / Dilution	-9.55%	-9.55%	-6.33%	-0.76%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 29, 2026

Data Sources Report a data error